Finalni program kongresa preuzmite ovdje
- ČETVRTAK 9.11.
- PETAK 10.11.
- SUBOTA 11.11.
- NEDJELJA 12.11.
DVORANA A (HALL A) | |
15:00 – 15:10 | OTVARANJE KONGRESA (CONGRESS OPENING) |
15:10 – 15:30 | Mario Šekerija Epidemiologija raka u Hrvatskoj – gdje smo i kuda idemo? (Cancer epidemiology in Croatia – where are we and where are we going?) |
15:30 – 16:00 | Anuška Budisavljević, Renata Kelemenić Ishodi liječenja i organizacija onkološke skrbi, komparacija Hrvatske i zemalja u okruženju (Treatment outcomes and organization of oncology care, comparison of Croatia and neighboring countries) |
16:00 – 16:45 | PANEL RASPRAVA Jesmo li na tragu smanjenja smrtnosti od zloćudnih bolesti i poboljšanja ishoda liječenja – kojih i kako ćemo ih pratiti? (Are we on track to reduce mortality from malignant diseases and improve treatment outcomes – which ones and how will we monitor them?) (Predstavnici stručnih društava HR i SLO, MiZ, HZJZ, HZZO, udruge bolesnika) (Representatives of professional societies of HR and SLO, MiZ, HZJZ, HZZO, patient association) |
16:45 – 17:05 | SEKCIJA SUPORTIVNO I PALIJATIVNO LIJEČENJE ONKOLOŠKIH BOLESNIKA (SECTION SUPPORTIVE AND PALLIATIVE TREATMENT OF ONCOLOGY PATIENTS) |
Maurizio Muscarritoli, Borislav Belev Pronto protokol (Pronto protocol) | |
17:05 – 17:20 | PAUZA ZA KAVU I RAZGLEDAVANJE POSTERA (COFFEE BREAK AND POSTER VIEWING) |
17:20 – 18:05 | SATELITSKI SIMPOZIJ ROCHE (SATELLITE SYMPOSIUM ROCHE) |
Put prema boljim ishodima liječenja (The path towards better treatment outcomes) Moderator (Moderator): Stjepko Pleština Predavači (Lecturers): Tomaš Büchler, Natalija Dedić Plavetić, Nina Dabelić | |
18:05 – 18:50 | SATELITSKI SIMPOZIJ AstraZeneca (SATELLITE SYMPOSIUM AstraZeneca) |
Precizna onkologija: Sudbina Pan-Tumor koncepta (Precision Oncology: Destiny of Pan-Tumour concept) Moderator (Moderator): Snježana Tomić Stjepko Pleština, Eduard Vrdoljak, Natalija Dedić Plavetić, Marko Jakopović | |
18:50 – 19:55 | SATELITSKI SIMPOZIJ BMS (SATELLITE SYMPOSIUM BMS) |
Razmjena iskustva liječenja terapijom temeljenom na nivolumabu različitih vrsta tumora i stadija bolesti Sharing experience of Nivolumab-based treatment across multiple tumor types and disease stages Moderator (Moderator): Stjepko Pleština | |
18:50 – 19:00 | Stjepko Pleština Uvod (Introduction) |
19:00 – 19:15 | Davorin Herceg Iskustvo u liječenju melanoma (Experience in melanoma) |
19:15 – 19:30 | Marko Jakopović Iskustvo u liječenju torakalnih tumora (MPM, NSCLC) (Experience in thoracic indications (MPM, NSCLC)) |
19:30 – 19:45 | Marija Gamulin Iskustvo u liječenju raka bubrega (Experience in RCC) |
19:45 – 19:55 | Rasprava (Discussion) |
20:00 – 21:00 | DOMJENAK DOBRODOŠLICE (WELCOME RECEPTION) |
DVORANA A (HALL A) | |
08:00 – 09:00 | SEKCIJA TUMORI SŽS, GLAVE I VRATA (CNS, HEAD&NECK SESSION) |
Moderatori (Moderators): Vesna Bišof, Ana Mišir Krpan, Zoran Rakušić, Marija Skoblar, Majana Soče, Ljubica Vazdar | |
08:00 – 08:15 | Ljubica Vazdar Novosti s ASCO i ESMO kongresa (News from the ASCO and ESMO congresses) |
08:15 – 08:30 | Marija Skoblar Vidmar Leptomeningealna karcinomatoza: dijagnostički i terapijski izazov (Leptomeningeal carcinomatosis: a diagnostic and therapeutic challenge) |
08:30 – 08:45 | Ana Mišir Krpan Profilaktičko zračenje mozga: pro et contra (Prophylactic brain irradiation: pro et contra) |
08:45 – 09:00 | Marin Prpić Primjena imunoterapije u nemetastatskom planocelularnom raku glave i vrata (Application of immunotherapy in non-metastatic squamous cell cancer of the head and neck) |
09:00 – 09:20 | SATELITSKI SIMPOZIJ EWOPHARMA (SATELLITE SYMPOSIUM EWOPHARMA) |
Uloga lenvatiniba u liječenju progresivnog karcinoma štitnjače refraktornog na radioaktivni jod (The role of lenvatinib in the treatment of progressive differentiated thyroid carcinoma, refractory to radioactive iodine) Borislav Belev | |
09:20 – 09:50 | SATELITSKI SIMPOZIJ MSD (SATELLITE SYMPOSIUM MSD) |
Pembrolizumab u liječenju metastatskog ili rekurentnog neresektabilnog HNSCC: Personalizirani pristup liječenju! Pembrolizumab in the treatment of metastatic or recurrent unresectable HNSCC: A personalized approach! Predavač / Speaker: Vesna Bišof | |
DVORANA B (HALL B) | |
09:00 – 09:30 | SATELITSKI SIMPOZIJ AstraZeneca (SATELLITE SYMPOSIUM AstraZeneca) |
ADAURA u kliničkoj praksi (ADAURA in clinical practice) | |
09:30 – 10:00 | SATELITSKI SIMPOZIJ ROCHE (SATELLITE SYMPOSIUM ROCHE) |
Mijenjamo zajedno ishode liječenja bolesnika s ranim rakom pluća (Changing together the clinical outcomes in early lung cancer) Moderator: Miroslav Samaržija Predavači: Sanja Pleština, Marko Jakopović | |
DVORANA A (HALL A) | |
10:00 – 11:00 | SEKCIJA TUMORI PLUĆA (LUNG TUMORS SECTION) |
Moderatori (Moderators): Marko Jakopović, Sanja Pleština, Miroslav Samaržija, Dragan Trivanović Panelisti (Panelists): Maja Hrabak Paar, Goran Madžarac, Tihana Pavić, Snježana Tomić | |
10:00 – 10:30 | Marko Jakopović, Lidija Ljubičić Rak pluća – Je li vrijeme za perioperativno liječenje raka pluća? (Lung cancer – Is it time for perioperative treatment of lung cancer?) |
10:30 – 11:00 | Dragan Trivanović, Iva Skočilić Lokalno uznapredovali rak pluća (Locally advanced lung cancer) |
11:00 – 11:30 | SEKCIJA SUPORTIVNO I PALIJATIVNO LIJEČENJE ONKOLOŠKIH BOLESNIKA (SECTION SUPPORTIVE AND PALLIATIVE TREATMENT OF ONCOLOGICAL PATIENTS) |
Invazivni postupci u palijativnoj medicini – kada i kome? (Invasive procedures in palliative medicine – when and for whom?) | |
11:00 – 11:15 | Sonja Badovinac Mjesto interventne pulmologije u palijativnom zbrinjavanju onkoloških bolesnika (The place of interventional pulmonology in the palliative care of cancer patients) |
11:15 – 11:30 | Dražen Perkov Uloga stentiranja u palijativnom zbrinjavanju onkoloških bolesnika sa sindromom gornje šuplje vene (The role of stenting in the palliative care of cancer patients with superior vena cava syndrome) |
11:30 – 11:45 | PAUZA ZA KAVU I RAZGLEDAVANJE POSTERA (COFFEE BREAK AND POSTER VIEWING) |
11:45 – 12:15 | SEKCIJA TUMORI PLUĆA (LUNG TUMORS SECTION) |
Moderatori (Moderators): Marko Jakopović, Sanja Pleština, Miroslav Samaržija, Dragan Trivanović Panelisti (Panelists): Maja Hrabak Paar, Goran Madžarac, Tihana Pavić, Snježana Tomić | |
Sanja Pleština, Ana Bačelić Gabelica Novosti u liječenju metastatskog raka pluća nemalih stanica (Innovations in the treatment of metastatic non-small cell lung cancer) | |
12:15 – 13:00 | SATELITSKI SIMPOZIJ MSD (SATELLITE SYMPOSIUM MSD) |
Pembrolizumab u liječenju ranog i metastatskog raka pluća – bez obzira na PD-L1 ekspresiju Vaših bolesnika Pembrolizumab in early and metastatic lung cancer treatment – regardless of PD-L1 expression Panelisti / Panelists: Marko Jakopović, Sanja Pleština | |
13:00 – 13:30 | SATELITSKI SIMPOZIJ PFIZER (SATELLITE SYMPOSIUM PFIZER) |
Optimalno prvolinijsko liječenje kod ALK+ NSCLC bolesnika (Optimal first-line treatment for metastatic ALK+ non-small cell lung cancer) Miroslav Samaržija Čimbenici koji određuju terapijski izbor u 1L (Factors that affecting therapeutic choice in 1L) Sanja Pleština Ima li razlike između ALK inhibitora u 1L? (Are there any differences among ALK inhibitors in 1L) Marko Jakopović Zašto primijeniti lorlatinib u 1L (Why to choose lorlatinib in 1L) | |
13:30 – 14:00 | SATELITSKI SIMPOZIJ AMGEN (SATELLITE SYMPOSIUM AMGEN) |
Učinkovitost sotorasiba u liječenju KRAS G12C-mutiranog NSCLC – novi podaci (New evidence on efficacy of sotorasib in the treatment of KRAS G12C mutated NSCLC) Moderator (Moderator): Marko Jakopović | |
13:30 – 13:45 | Sanja Pleština Sotorasib u liječenju bolesnika s KRAS G12C mutiranim NSCLC i presadnicama u mozgu Sotorasib in Patients With KRAS G12C-Mutated NSCLC and Brain Metastases |
13:45 – 13:55 | Dražena Srdić Prikaz bolesnika liječenog sotorasibom u KPB Jordanovac (A patient treated with sotorasib – case presentation) |
13:55 – 14:00 | Rasprava (Q&A session) Marko Jakopović, Sanja Pleština, Dražena Srdić |
DVORANA B (HALL B) | |
12:30 – 13:00 | SATELITSKI SIMPOZIJ AMGEN (SATELLITE SYMPOSIUM AMGEN) |
PARADIGM studija – jučer, danas, sutra – što smo sve saznali o panitumumabu? Moderator (Moderator): Stjepko Pleština | |
12:30 – 12:40 | Stjepko Pleština PARADIGM studija – potvrda naših iskustava u liječenju metastatskog kolorektalnog carcinoma – uvod |
12:40 – 12:50 | Borislav Belev PARADIGM studija – što nam je sve pokazao panitumumab |
12:50 – 13:00 | Domina Kekez Nove smjernice za liječenje metastatskog kolorektalnog karcinoma i što to znači za naše pacijente? |
13:00 – 13:30 | SATELITSKI SIMPOZIJ ROCHE (SATELLITE SYMPOSIUM ROCHE) |
IMbrave – hrabrost na svakom koraku u liječenju HCC-a (IMbrave – courage at every step of the HCC patient’s journey) Moderator (Moderator): Stjepko Pleština Predavači (Lecturers): Tajana Filipec Kanižaj, Juraj Prejac, Hrvoje Silovski | |
13:30 – 14:00 | SATELITSKI SIMPOZIJ SERVIER (SATELLITE SYMPOSIUM SERVIER) |
Nove terapijske opcije za poboljšanje rezultata liječenja bolesnika s tumorima probavnog sustava (New treatment strategies in GI tumors to improve patient outcomes) | |
13:30 – 13:45 | Stjepko Pleština Produljenje kontinuuma skrbi u bolesnika s mCRC (Further extending the continuum of care in mCRC) |
13:45 – 14:00 | Eduard Vrdoljak Promjena terapijskog pristupa u liječenju kolangiokarcinoma: Koja je uloga molekularnog testiranja? (Changing treatment landscape in cholangiocarcinoma: What is the role of molecular testing?) |
14:00 – 15:00 | RUČAK (LUNCH) |
DVORANA B (HALL B) | |
15:00 – 15:30 | SATELITSKI SIMPOZIJ JANSSEN (SATELLITE SYMPOSIUM JANSSEN) |
Novosti u liječenju NSCLC-a s EGFR egzon20ins mutacijom – ciljana terapija (Expanding horizons for management of NSCLC with EGFR exon 20ins – targeted therapy) Marko Jakopović, Sanja Pleština, Marijo Boban | |
15:30 – 16:00 | SATELITSKI SIMPOZIJ A&B d.o.o (Biocartis) (SATELLITE SYMPOSIUM A&B d.o.o (Biocartis)) |
Molekularna dijagnostika raka pluca: NGS, Idylla GeneFusion test ili oboje Lung cancer molecular diagnostics: NGS, Idylla Genefusion Assay or both Moderator: Snježana Tomić Panelisti: Lovorka Batelja-Vuletić, Jasna Radić, Snježana Tomić | |
DVORANA A (HALL A) | |
15:00 – 15:30 | SATELITSKI SIMPOZIJ AstraZeneca (SATELLITE SYMPOSIUM AstraZeneca) |
Nove perspektive u liječenju GI tumora: Što nam otkrivaju studije TOPAZ i HIMALAYA (New perspectives in the treatment of GI tumors: What TOPAZ and HIMALAYA studies reveal) Juraj Prejac | |
15:30 – 16:00 | SATELITSKI SIMPOZIJ GENESISPHARMA (SATELLITE SYMPOSIUM GENESISPHARMA) |
Pemazyre (pemigatinib) u liječenju odraslih osoba s lokalno uznapredovalim ili metastatskim kolangiokarcinomom (Pemazyre (pemigatinib) for the treatment of adults with locally advanced or metastatic cholangiocarcinoma) Stjepko Pleština, Juraj Prejac | |
DVORANA A (HALL A) | |
16:00 – 18:00 | SEKCIJA PROBAVNI TUMORI (DIGESTIVE TUMORS SECTION) |
Moderatori (Moderators): Borislav Belev, Renata Dobrila Dintinjana, Stjepko Pleština, Juraj Prejac | |
16:00 – 16:15 | Marin Golčić Personalizirana terapija u GI-tumorima – koliko smo napredovali? (Personalized therapy in GI tumors – how far have we progressed?) |
16:15 – 16:45 | Dora Tomek Hamzić Lokalno uznapredovali karcinom gušterače (Locally advanced pancreatic cancer) Prikaz slučaja (Case presentation) Panel rasprava (Panel discussion): Dražen Perkov, Nikša Librenjak, Igor Petrović, Majana Soče |
16:45 – 17:00 | PAUZA ZA KAVU I RAZGLEDAVANJE POSTERA (COFFEE BREAK AND POSTER VIEWING) |
17:00 – 17:30 | Domina Kekez HCC – koji je optimalni koncept liječenja? (HCC – what is the optimal treatment concept?) Prikaz slučaja (Case presentation) Panel rasprava (Panel discussion): Anna Mrzljak, Igor Petrović, Juraj Prejac, Dražen Perkov |
17:30 -17:50 | Josip Joachim Grah Uloga stereotaksijske radioterapije u lijecenju primarnih tumora jetre (The role of stereotaxic radiotherapy in the treatment of primary liver tumors) |
17:50 – 18:10 | Majana Soče Znamo li što je optimalno liječenje raka rektuma? (Do we know what is the optimal treatment for rectal cancer?) |
18:10 – 18:30 | Dragan Trivanović Novosti sa AACR, koji nam novi lijekovi dolaze u budućnosti? (News from AACR, what new drugs are coming our way in the future?) |
DVORANA A (HALL A) | |
08:00 – 09:00 | SEKCIJA MELANOM, MEZENHIMALNI I RIJETKI TUMORI (MELANOMA, SARCOMA AND RARE TUMORS SECTION) |
08:00 – 08:30 | MELANOM / MELANOMA Panelisti (Panelists): Jasmina Marić Brozić, Nina Dabelić, Davorin Herceg, Luka Simetić, Daška Štulhofer-Buzina |
08:00 – 08:15 | Davorin Herceg Europska i regionalna suradnja u registru za melanom – EUMelaReg (EUMelaReg- European Melanoma Registry“- european and regional collaboration) |
08:15 – 08:25 | Krešimir Blažičević Ishodi liječenja metastatskog melanoma u Hrvatskoj na temelju podataka iz EUMelareg-a (Treatment outcomes for patients with metastatic melanoma in Croatia – EUMelaReg data analysis) |
08:25 – 08:30 | Diskusija (Discussion) |
08:30 – 09:00 | SARKOMI / SARCOMA Panelisti (Panelists): Ivan Bohaček, Snježana Dotlić, Davorin Herceg, Luka Simetić, Marko Šimunović |
08:30 – 08:40 | Tatjana Ladenhauser Iskustva u liječenju lokaliziranog osteosarkoma (Single center experience- localized osteosarcoma treatment) |
08:40 – 08:50 | Kata Međugorac Prikaz slučaja/case presentation: Neoadjuvantna kemoterapija kod sarkoma- multidisciplinarni pristup (Neoadjuvant chemotherapy for sarcoma – multidisciplinary approach) |
08:50 – 09:00 | Diskusija (Discussion) |
DVORANA A (HALL A) | |
09:00 – 09:30 | SATELITSKI SIMPOZIJ MEDISON PHARMA (SATELLITE SYMPOSIUM MEDISON PHARMA) |
Metastatski melanom uvee: što trebamo znati (Metastatic melanoma of the uvea: what we need to know) Moderator: Stjepko Pleština Nina Dabelić Melanom uvee i mogućnosti liječenja (Uveal melanoma and treatment options) Luka Simetić Naša iskustva (Our experiences) | |
09:30 – 10:15 | SATELITSKI SIMPOZIJ MSD (SATELLITE SYMPOSIUM MSD) |
Uz lijek Keytruda® mijenjamo ishode liječenja bolesnika s melanomom With Keytruda®, we are changing treatment outcomes for melanoma patients Panelisti / Panelists: Davorin Herceg, Luka Simetić | |
DVORANA B (HALL B) | |
09:00 – 09:30 | SATELITSKI SIMPOZIJ PFIZER (SATELLITE SYMPOSIUM PFIZER) |
Put pacijenta s metastatskim rakom dojke – 5 godina iskustva sa palbociklibom (Mapping the mBC patient journey – 5 years experience with Palbociclib) Ljubica Vazdar, Mario Nalbani, Anuška Budisavljević | |
09:30 – 10:15 | ZNANSTVENI SIMPOZIJ NOVARTIS (SCIENTIFIC SYMPOSIUM NOVARTIS) |
Rani rak dojke (Early breast cancer) | |
09:30 – 09:35 | Stjepko Pleština Uvod (Introduction) |
09:35 – 09:55 | Dejan Jurić CDK4/6i u ranom karcinomu dojke (CDK4/6i in early breast cancer) |
09:55 – 10:15 | Rasprava/Discussion Natalija Dedić Plavetić, Dejan Jurić, Stjepko Pleština, Eduard Vrdoljak |
10:15 – 10:30 | PAUZA ZA KAVU I RAZGLEDAVANJE POSTERA (COFFEE BREAK AND POSTER VIEWING) |
DVORANA A (HALL A) | |
10:30 – 12:30 | SEKCIJA RAK DOJKE (BREAST CANCER SECTION) |
Uključivanje novih terapijskih opcija u liječenju raka dojke – između želja i stvarnosti” (Implementation of novel therapeutic options in breast cancer treatment – between wishful thinking and reality) Moderatori (Moderators): Natalija Dedić Plavetić, Anuška Budisavljević Panelisti (Panelists): Dejan Jurić, Simona Borštnar, Marija Ban, Tajana Silovski, Renata Kelemenić-Dražin, Marijana Jazvić | |
10:30 – 11:00 | Mario Nalbani Pregled novosti u liječenu raka dojke; ASCO, ESMO, SABCS i SGBCC (Overview of news in breast cancer treatment; ASCO, ESMO, SABCS i SGBCC) |
11:00 – 11:25 | Karla Zekulić, Anamarija Kovač Peić Trostruko negativan rak dojke, prikaz slučaja i rasprava (Triple negative breast cancer, case report and panel discussion) |
11:25 – 11:50 | Ivana Matanić, Nikolina Lonjak HR+ pozitivan rak dojke, príkaz slučaja i rasprava (HR+ breast cancer, case report and panel discussion) |
11:50 – 12:15 | Jurica Vrbanec, Marina Popović HER2 pozitivan rak dojke, prikaz slučaja i rasprava (HER2+ breast cancer, case report and panel discussion) |
12:15 – 12:30 | Završna riječ i zaključci panela (Session wrap up and panel conclusions) |
DVORANA A (HALL A) | |
12:30 – 13:00 | SATELITSKI SIMPOZIJ ELI LILLY (SATELLITE SYMPOSIUM ELI LILLY) |
Kad je rizik visok dajte joj nadu, i više! (When the risk is high give her hope, and more!) Moderator (Moderator): Stjepko Pleština | |
12:30 – 12:35 | Uvod moderatora (Moderator’s introduction) |
12:35 – 12:45 | Paula Podolski Uloga abemacikliba u današnjoj kliničkoj praksi (The role of abemaciclib in today’s clinical practice) |
12:45 – 12:55 | Mario Nalbani monarchE – Održana učinkovitost abemacikliba (monarchE – Sustained efficacy of abemaciclib) |
12:55 – 13:00 | Zaključak moderatora (Moderator’s Conclusion) |
13:00 – 13:45 | SATELITSKI SIMPOZIJ AstraZeneca (SATELLITE SYMPOSIUM AstraZeneca) |
PARPe diem – Lynparza u liječenju raka jajnika, dojke i prostate (PARPe diem – Lynparza in the treatment of ovarian, breast and prostate cancer) Moderator (Moderator): Tihana Boraska Jelavić Erik Škof, Tajana Silovski, Tomislav Omrčen, Ivan Milas | |
13:45 – 14:05 | SATELITSKI SIMPOZIJ MEDICOPHARMACIA (SATELLITE SYMPOSIUM MEDICOPHARMACIA) |
Trodelvy u liječenju metastatskog TNBC – prikaz slučaja (Trodelvy in the treatment of metastatic TNBC – case report) Anuška Budisavljević | |
14:05 – 15.00 | RUČAK (LUNCH) |
DVORANA A (HALL A) | |
15:00 – 16:00 | SEKCIJA MLADIH ONKOLOGA (SECTION OF YOUNG ONCOLOGISTS) |
“Survivorship” onkoloških bolesnika (Survivorship of oncology patients) | |
15:00 – 15:15 | Iva Nikles Što je uopće „survivorship“ i zašto je važan? (What is survivorship anyway and why is it important?) |
15:15 -15:30 | Ivana Kukec Psiho-socio-ekonomski aspekti onkoloških bolesnika (Psycho-socio-economic aspects of oncology patients) |
15:30 – 16:00 | Panel rasprava na praktičnom primjeru bolesnice s rakom dojke (Panel discussion on the practical example of a patient with breast cancer) Voditelj panela (Panel leader): Martina Mladinović Panelisti (Panelists): Hrvoje Vinter, Ivona Poljak, Marina Popović, Iva Nikles, Mario Nalbani |
16:00 – 17:00 | SEKCIJA GINEKOLOŠKIH TUMORA (SECTION OF GYNECOLOGICAL TUMORS) |
Moderator (Moderator): Višnja Matković Panelisti (Panelists): Marija Milković Periša, Tihana Boraska Jelavić, Josip Kuharić | |
16:00 – 16:15 | Mihaela Trajbar Terapija održavanja u prvoj liniji liječenja epitelnog raka jajnika visokog stupnja nediferenciranosti – PARP inhibitori kao monoterapija ili u kombinaciji sa bevacizumabom (Maintenance therapy in the first line of treatment of high grade epithelial ovarian cancer – PARP inhibitors monotherapy or in combination with bevacizumab) |
16:15 – 16:30 | Marija Milković Periša Molekularni biomarkeri u karcinomu endometrija – osvrt patologa (New molecular biomarkers in endometrial cancer – view of a pathologist) |
16:30 – 16:45 | Ida Čepulić Maravić Liječenje metastatskog karcinoma endometrija – novosti i prostor za napredak (Treatment of metastatic endometrial cancer – news and possibilities for improvement) |
16:45 – 17:00 | Tihana Boraska Jelavić Liječenje metastatskog karcinoma vrata maternice – uloga imunoterapije (News in the treatment of metastatic cervical cancer – the role of immunotherapy) |
17:00 – 17:15 | PAUZA ZA KAVU I RAZGLEDAVANJE POSTERA (COFFEE BREAK AND POSTER VIEWING) |
17:15 – 17:45 | SATELITSKI SIMPOZIJ NOVARTIS (SATELLITE SYMPOSIUM NOVARTIS) |
Kisqali (ribociklib) – Živjeti duže uz održanu ili poboljšanu kvalitetu života (Kisqali (ribociclib) – Living longer with maintained or improved quality of life) Tajana Silovski, Marina Popović | |
17:45 – 18:30 | SKUPŠTINA HDIO (članovi HDIO) HDIO ASSEMBLY (HDIO members) |
DVORANA B (HALL B) | |
14:00 – 18:00 | SEKCIJA ZA PACIJENTE (SECTION FOR PATIENTS) |
14:00 – 14:05 | Stjepko Pleština i predstavnica pacijenata Otvaranje Sekcije za pacijente (Section Opening) |
14:05 – 14:30 | Eduard Vrdoljak Zašto Onkologija? (Why Oncology?) |
14:30 – 14:45 | Natalija Dedić Plavetić Precizna medicina i personalizirano liječenje (Precision medicine and personalized treatment) |
14:45 – 15:00 | Višnja Matković Liječenje bolesnica s rakom jajnika (Treatment of patients with ovarian cancer) |
15:00 – 15:15 | Ana Bačelić Gabelica Suportivno i palijativno liječenje onkoloških bolesnika (Cancer patients supportive and palliative treatment) |
15:15 – 15:30 | Diskusija (Discussion) |
15:30 – 16:00 | PAUZA ZA KAVU (COFFEE BREAK) |
16:00 – 16:15 | Sanja Pleština Predstavljanje ESMO vodiča za bolesnike “Što je rak pluća nemalih stanica” (Presentation of the ESMO guide for patients “What is non-small cell lung cancer”) |
16:15 – 16:30 | Paula Podolski Liječenje bolesnica s rakom dojke kroz vrijeme (Treatment of breast cancer patients over time) |
16:30 – 16:45 | Anuška Budisavljević Kvaliteta života onkoloških bolesnika (Quality of life of oncology patients) |
16:45 – 17:00 | Marina Popović Benefiti psihoonkološke pomoći pacijentima iz perspektive onkologa i „survivorship“ (Benefits of psycho-oncology assistance to patients from the perspective of oncologists and “survivorship”) |
17:00 – 17:30 | „Position paper“ udruga i Inovativne farmaceutske inicijative “Associations’ and Innovative pharmaceutical initiative’s “Position paper” Moderator/Moderator: Ljiljana Vukota Panelisti/Panelists: predstavnici udruga, Inovativne farmaceutske inicijative i onkologije (representatives of associations, innovative pharmaceutical initiative and oncology) |
17:30 – 17:35 | Zatvaranje programa Sekcije (Section Closing) |
20.00 | KONGRESNA VEČERA (CONGRESS DINNER) |
DVORANA A (HALL A) | |
08:30 – 09:15 | SATELITSKI SIMPOZIJ ASTELLAS (SATELLITE SYMPOSIUM ASTELLAS) |
Astellas iskustvo i inovacija: putovanje dugo 10 godina i početak novog pravca u onkologiji (Astellas experience and innovation: a 10-year journey and the beginning of a new direction in oncology) | |
08:30 – 09:00 | Što nam nosi Xtandi u svakodnevnom radu pri dugotrajnom liječenju bolesnika s uznapredovalim hormonski osjetljivim rakom prostate (What Xtandi brings to us in daily work during the long-term treatment of patients with advanced hormone-sensitive prostate cancer) Panel diskusija (Panel discussion): Marija Gamulin, Zrna Antunac Golubić, Jasmin Bektić |
09:00 – 09:15 | Što nam donosi Padcev u liječenju lokalno uznapredovalog i metastatskog urotelnog karcinoma? (What does Padcev bring to us in the treatment of locally advanced and metastatic urothelial carcinoma) Tomislav Omrčen |
09:15 – 10:00 | SATELITSKI SIMPOZIJ MERCK (SATELLITE SYMPOSIUM MERCK) |
Održavanje s lijekom Bavencio® u 1. liniji mUC (Maintenance with Bavencio® in 1. line mUC) Milena Gnjidić Javelin Bladder 100 (Javelin Bladder 100) Jure Murgić Iskustva u primjeni lijeka Bavencio® Odgovori na ključna pitanja kliničara kroz raspravu (Experiences in the use of Bavencio® Answers to clinicians’ key questions through discussion) | |
10:00 – 10:30 | SATELITSKI SIMPOZIJ JANSSEN (SATELLITE SYMPOSIUM JANSSEN) |
Zašto izabrati lijek Erleada u liječenju raka prostate? (Why choose Erleada for prostate cancer treatment?) Milena Gnjidić, Renata Kelemenić Dražin, Nikola Bulj | |
10:30 – 11:00 | SATELITSKI SIMPOZIJ NOVARTIS (SATELLITE SYMPOSIUM NOVARTIS) |
Iskorak u novu dimenziju u liječenju mCRPC-a (Stepping out into a new dimension in mCRPC treatment) Marija Gamulin | |
11:00 – 11:15 | PAUZA ZA KAVU I RAZGLED POSTERA (COFFEE BREAK AND POSTER VIEW) |
11:15 – 12:45 | SEKCIJA UROGENITALNI TUMORI (UROGENITAL TUMORS SECTION) |
Moderatori (Moderators): Borislav Belev, Milena Gnjidić | |
11:15 – 11:45 | Maja Baučić, Ivan Vičić Prikaz slučaja (Case preseentation): Uloga nuklearne medicine u dijagnostici karcinoma prostate: PSMA PET-CT (The role of nuclear medicine in the diagnosis of prostate cancer: PSMA PET-CT) Marija Gamulin, Milena Gnjidić, Tvrtko Hudolin Panel rasprava (Panel discussion): Primjena dijagnostičkih metoda nuklearne medicine u svakodnevnoj praksi (Application of diagnostic methods of nuclear medicine in everyday practice) |
11:45 – 12:10 | Metastatski hormon-osjetljivi karcinom prostate – kako odabrati ADT-partnera? (Metastatic hormone-sensitive prostate cancer – how to choose an ADT partner?) Martina Mladinović – prikaz slučaja (case presentation) Panel rasprava (Panel discussion): Vesna Bišof, Tomislav Omrčen, Tvrtko Hudolin, Mislav Čonkaš, Lidija Kocić |
12:10 – 12:35 | Zrna Antunac Golubić Novosti u liječenju urotelnog karcinoma (News in the treatment of urothelial cancer) Panel rasprava (Panel discussion): Mirko Bakula, Zrna Antunac Golubić, Stela Bulimbašić, Marijana Jazvić |
12:35 – 12:45 | Anamarija Kovač Peić Izazovi i iskustva u liječenju uroonkoloških bolesnika u nekliničkim centrima (Challenges and experiences in the treatment of uro-oncology patients in non-clinical centers) |
12:45 – 13:15 | SEKCIJA POTPORNE I PALIJATIVNE MEDICINE (SUPPORTIVE AND PALLIATIVE TREATMENT SECTION) |
Razgovori o skrbi na kraju života (Conversations about end-of-life care) Moderator: Sanja Pleština | |
12:45 – 12:55 | Ana Borovečki Što znači dobra smrt za Hrvate? (What does a good death mean for Croats?) |
12:55 – 13:00 | Ivana Kukec Prikaz rezultata interne ankete (Presentation of the results of the internal survey) |
13:00 – 13:15 | Panel rasprava (Panel discussion): (pro et contra) – Da li umrijeti kod kuće ili u ustanovi? (Should you die at home or in an institution?) Panelisti (Panelists): Sanja Pleština, Ana Borovečki, Ivana Kukec, Antonija Salamun, Ana Kotarski, Ružica Valent, Ivona Poljak |
13:15 – 14:00 | BEST OF HDIO – Proglašenje najboljih radova i zatvaranje kongresa (Announcement of the best papers and closing of the Congress) |